trial
as of 2026-07-01Salsalate as an Adjunctive Treatment for Patients With Schizophrenia
NCTId NCT01578486
at a glance
Phase 4 · Completed
Enrollment 17 (actual)
Sponsored by University of Massachusetts, Worcester
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
17 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2011-06
Primary completion
2015-07
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of Massachusetts, WorcesterLead Sponsor
National Institutes of Health (NIH)Collaborator
Investigators
2
Xiaoduo Fan, MD, MPH, MSPrincipal Investigator
Matthew R Goodnow, BSStudy Director
Sites
1 total
Worcester, United States
Facts & assertions
4 sourced
Enrollment
17
Phase
PHASE4
Primary Completion Date
2015-07
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person
person